Cargando…

Moving the Dial on Airway Inflammation in Response to Trikafta in Adolescents with Cystic Fibrosis

Detalles Bibliográficos
Autores principales:	Lepissier, Agathe, Bonnel, Anne Sophie, Wizla, Nathalie, Weiss, Laurence, Mittaine, Marie, Bessaci, Katia, Kerem, Eitan, Houdouin, Véronique, Reix, Philippe, Marguet, Christophe, Sermet-Gaudelus, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037474/ https://www.ncbi.nlm.nih.gov/pubmed/36599047 http://dx.doi.org/10.1164/rccm.202210-1938LE

Ejemplares similares

Chest physiotherapy enhances detection of Pseudomonas aeruginosa in nonexpectorating children with cystic fibrosis
por: Marguet, Christophe, et al.
Publicado: (2021)

Profiling the response to lumacaftor‐ivacaftor in children with cystic between fibrosis and new insight from a French‐Italian real‐life cohort
por: Cornet, Matthieu, et al.
Publicado: (2022)

Novel reaction to new cystic fibrosis medication Trikafta
por: Stashower, Julian, et al.
Publicado: (2021)

THE IMPACT OF TRIKAFTA (ELEXACAFTOR/IVACAFTOR/TEZACAFTOR) ON PATIENTS WITH CYSTIC FIBROSIS WITH COVID-19
por: MILES, B., et al.
Publicado: (2022)

Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta
por: Liessi, Nara, et al.
Publicado: (2020)

A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
por: Zaher, Anas, et al.
Publicado: (2021)

The cystic fibrosis treatment Trikafta affects the growth, viability, and cell wall of Aspergillus fumigatus biofilms
por: Jones, Jane T., et al.
Publicado: (2023)

Moving the Dial on Heart Failure Patient Adherence Rates
por: Makris, Eleanna, et al.
Publicado: (2020)

The CF-CIRC study: a French collaborative study to assess the accuracy of Cystic Fibrosis diagnosis in neonatal screening
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2006)

Trikafta—Extending Its Success to Less Common Mutations
por: Bentur, Lea, et al.
Publicado: (2022)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999)

Molecular Structures Reveal Synergistic Rescue of Δ508 CFTR by Trikafta Modulators
por: Fiedorczuk, Karol, et al.
Publicado: (2022)

Dial Down the Drama
por: O'Grady, Colleen
Publicado: (2015)

DIALS as a toolkit
por: Winter, Graeme, et al.
Publicado: (2021)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
por: Pranke, Iwona, et al.
Publicado: (2019)

Phenotyping Rare CFTR Mutations Reveal Functional Expression Defects Restored by TRIKAFTA(TM)
por: Laselva, Onofrio, et al.
Publicado: (2021)

Aging: Dial M for Mitochondria
por: Hur, Jae H., et al.
Publicado: (2010)

Robust background modelling in DIALS
por: Parkhurst, James M., et al.
Publicado: (2016)

Tuning the dials of Synthetic Biology
por: Arpino, James A. J., et al.
Publicado: (2013)

Effect of Trikafta on bone density, body composition and exercise capacity in CF: A pilot study
por: Gur, Michal, et al.
Publicado: (2022)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2021)

Diffraction-geometry refinement in the DIALS framework
por: Waterman, David G., et al.
Publicado: (2016)

Electron diffraction data processing with DIALS
por: Clabbers, Max T. B., et al.
Publicado: (2018)

Phenotypic Presentations of Cystic Fibrosis in Children of African Descent
por: Mayer Lacrosniere, Sophie, et al.
Publicado: (2021)

Myeloperoxidase Promoter Polymorphism −463G Is Associated With More Severe Clinical Expression of Cystic Fibrosis Pulmonary Disease
por: Reynolds, Wanda F., et al.
Publicado: (2006)

Mucoviscidosis: fisiopatología, genética, aspectos clínicos y terapéuticos
por: Noël, S., et al.
Publicado: (2020)

Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal Disease
por: Gauthier, Sebastien, et al.
Publicado: (2020)

Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination
por: Veit, Guido, et al.
Publicado: (2020)

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849 + 10 kb C-to-T splicing mutation
por: Oren, Yifat S., et al.
Publicado: (2021)

Knobmanship: Dialing Up Understanding of VAE Triggers
por: Cawcutt, Kelly, et al.
Publicado: (2021)

Mycobacterium abscessus and Children with Cystic Fibrosis
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2003)

Airway Surface Liquid pH Regulation in Airway Epithelium Current Understandings and Gaps in Knowledge
por: Zajac, Miroslaw, et al.
Publicado: (2021)

Are we moving the dial? Canadian health research funding trends for women’s health, 2S/LGBTQ + health, sex, or gender considerations
por: Stranges, Tori N., et al.
Publicado: (2023)

Graft Retensioning by Dialing of Suture Disk on Tibial-Side Fixation in Arthroscopic Anterior Cruciate Ligament Reconstruction: Pathak Pune Dialing Technique
por: Pathak, Shirish S., et al.
Publicado: (2020)

Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.
por: Sermet-Gaudelus, I, et al.
Publicado: (1999)

β‐adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
por: Zampoli, Marco, et al.
Publicado: (2022)

DIAL: A Platform for real-time Laboratory Surveillance
por: Mukhi, Shamir N, et al.
Publicado: (2010)

Dial-in Topological Metamaterials Based on Bistable Stewart Platform
por: Wu, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rdv2vevskguu8eo6i3qgf8nsum